NERI02

NERI02 Chemische Eigenschaften,Einsatz,Produktion Methoden

Biochem/physiol Actions

NSC130813 blocks protein-protein interactions between XPF and ERCC1, two proteins involved in nucleotide excision repair (NER). The compound, NSC130813, blocks repair of DNA damage induced by platinum-based ctyotoxic drugs and DNA alkylating agents. NSC130813 synergistically potentiates cell death in cancer cell lines treated with cisplatin or mitomycin C.

NERI02 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

NERI02 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Accela ChemBio Inc.	(+1)-858-699-3322	info@accelachem.com	United States	19965	58
Wuxi Rejoys chemical Technology Co., Ltd.	0510-86103381	sales@rejoyschem.com	CHINA	976	58
Aladdin Scientific	+1-833-552-7181	sales@aladdinsci.com	United States	57511	58
Shanghai YuanQi Biotechnology Co., Ltd.	+86-2332782371 +86-18120098618	sales@adobechem.com	China	1250	50
Sigma-Aldrich	021-61415566 800-8193336	orderCN@merckgroup.com	China	51471	80
Adobe Chem Co., Ltd.	2332782371	adobechem@qq.com	China	7980	58
Energy Chemical	021-58432009 400-005-6266	marketing1@energy-chemical.com	China	44894	58
cjbscvictory	13348960310 13348960310	3003867561@qq.com	China	9946	58
Shanghai Sunway Pharmaceutical Technology Co.,Ltd.	021-51816796-820 13611835272	sales2@sunwaypharm.com	China	44498	58
chemmole	400-168-9330 15013243073	597760450@qq.com	China	2942	58

---

• 4-[(6-Chloro-2-methoxy-9-acridinyl)amino]-2-[(4-methyl-1-piperazinyl)methyl]-phenol trihydrochloride
• F06
• NERI02
• NSC130813
• HM03 trihydrochloride
• NSC130813 >=98% (HPLC)
• 1082532-95-3